Generate Biomedicines
Generate Biomedicines operates at the nexus of machine learning, biological engineering, and medicine, using its proprietary Generate Platform to revolutionize the creation of novel medicines.
Company Overview
Generate Biomedicines exists at the intersection of machine learning, biological engineering, and medicine. The company pioneers generative biology with the goal of creating breakthrough medicines. By leveraging The Generate Platform, the company fundamentally changes the way medicines are made, offering an expanded breadth of technical possibilities.
The Generate Platform
The Generate Platform is a key innovation from Generate Biomedicines, capable of generating novel medicines on demand. The platform studies millions of proteins to understand the generalizable rules by which nature encodes function. Using these learned rules, it generates novel medicines with specific therapeutic functions. This technology allows for the rapid development of medicines across multiple therapeutic modalities with unprecedented speed and success rates.
Applications of Generative Biology
Generative biology, as advanced by Generate Biomedicines, represents a fundamental shift in therapeutic development. By applying machine learning to biological engineering, the company can generate medicines that were previously impossible to create. This new approach has allowed the company to generate, build, and test 42,000 proteins, significantly advancing the field of therapeutic development.
Research and Development Facilities
Generate Biomedicines operates over 140,000 square feet of space in new locations at Boynton Yards and Andover. These facilities support the company's expansive R&D efforts, providing the infrastructure needed to study proteins, develop new therapeutic modalities, and rapidly generate novel medicines. The advanced capabilities of these locations enable the company to remain at the forefront of biomedical innovation.